affordable pharmaceuticals

Personal Medication Importation: Navigating CBP Regulations

Brian Rogers0569 views

The U.S. Customs and Border Protection Agency generally prohibits the importation of more than a 90-day supply of medication. This policy aims to balance the need for drug safety with recognizing that many Americans turn to international sources for their prescription medications due to high domestic prices or availability issues. Despite strict regulations, the FDA inspects less than 1% of all packages presumed to contain drugs, significantly reducing the likelihood of small personal shipments being intercepted. This article explores the complexities and implications of current import regulations and highlights the efforts of organizations like Ashvin Medicara to advocate for better access to affordable medications.

Read more

Commercial Protectionism vs. Affordable Pharmaceuticals: Navigating the Complex Landscape of U.S. Healthcare Policy

Brian Rogers0155 views

In the ongoing debate between commercial protectionism and the accessibility of affordable pharmaceuticals, the United States finds itself at a critical juncture. While the FDA’s stringent regulations on imported generics from countries like India are justified by health concerns, there is a growing perception that these measures increasingly serve commercial interests. Critics argue that the influence of Big Pharma has led to policies that prioritize corporate profits over consumer welfare, resulting in higher healthcare costs for Americans. This article explores the origins of these regulatory measures, the role of pharmaceutical lobbying, and the economic impacts of protectionism, calling for reforms to balance safety with affordability and accessibility.

Read more

From Constitution to Court: Legal Grounds for International Medication Access

Brian Rogers0126 views

The ability of Americans to make autonomous healthcare decisions, including the choice of purchasing affordable pharmaceuticals from international sources like India, raises significant legal and ethical questions. While the U.S. Constitution does not explicitly grant the right to affordable healthcare or the importation of foreign medications, several amendments and legal precedents suggest that such activities could be protected under broader interpretations of individual rights and liberties. This article delves into the legal cases and constitutional interpretations that support the argument that blocking access to affordable pharmaceuticals may infringe upon fundamental human rights. Key cases and amendments, such as the Ninth and Fourteenth Amendments, emphasize the importance of personal choice and autonomy in healthcare decisions, highlighting the potential constitutional violations of restricting access to cost-effective medications

Read more